No abstract

No abstract

No abstract

No abstract

Catheter-related infections are a common worldwide health problem, highlighting the need for antimicrobial catheters. Here, antibacterial potential of graphene nanoplatelets (GNP) incorporated in the commonly used polymer for catheter manufacture—polyurethane (PU)—is investigated. Two strategies are explored: melt-blending, producing a composite, and dip coating, where a composite layer is deposited on top of PU. GNP with different lateral sizes and oxidation degrees—GNP-M5, GNP-M15, GNP-M5ox, GNP-M15ox—are applied in both strategies, and the antimicrobial potential towards Staphylococcus epidermidis of GNP dispersions and GNP-containing PU evaluated. As dispersions, oxidized and smaller GNP powders (GNP-M5ox) inhibit 74% bacteria growth at 128 µg/mL. As surfaces, GNP exposure strongly impacts their antimicrobial profile: GNP absence at the surface of composites yields no significant effects on bacteria, while by varying GNP: PU ratio and GNP concentration, coatings enhance GNP exposure, depicting an antimicrobial profile. Oxidized GNP-containing coatings induce higher antibacterial effect than non-oxidized forms, particularly with smaller GNPox, where a homogeneous layer of fused platelets is formed on PU, leading to 70% reduction in bacterial adhesion and 70% bacterial death. This pioneering work unravels how to turn a polymer clinically used to produce catheters into an antimicrobial surface, crucial to reducing risk of infection associated with catheterization.

Infections and thrombus formation are major concerns for the success of blood‐contacting medical devices. Antimicrobial coatings based on antimicrobial peptides (AMPs) are described as promising strategies to fight biomaterial‐associated infections. However, their efficiency in the presence of plasma and their effect on platelets adhesion/activation, essential for blood contact applications, is not known. In this work, the AMP cecropin–melittin (CM) is covalently immobilized onto polyurethane (PU) films envisaging a coating for intravascular catheters. Immobilization is done by dip‐coating of a layer of gold nanoparticles (Au NPs) functionalized with NH2 and COOH terminated polyethylene glycol (PEG). Surfaces characterized using scanning electron microscopy (SEM), X‐ray photoelectron spectroscopy (XPS), quartz crystal microbalance with dissipation (QCM‐D), and colorimetric assays reveal a stable and homogeneous coating distribution. CM coating significantly reduces Staphylococcus epidermidis adhesion to PU films (≈80% in PBS). Its bactericidal activity is not affected in the presence of 1% human plasma (hPlasma) proteins with 65% reduction on viable bacteria comparing to PU. Moreover, CM coating is able to prevent platelet adhesion/activation to PU films (≈95% in PBS). This effect is also observed when surfaces are precoated with hPlasma. Overall, the developed antimicrobial coating demonstrates great potential to prevent bacterial infections on PU devices without instigating platelet adhesion/activation.

Tilia platyphyllos Scop., is a popular broad-leave tree, native to central and southern Europe. Hydroethanolic extracts rich in phenolic compounds obtained from T. platyphyllos Scop. showed in vitro antioxidant, anti-inflammatory...

ATRX is a chromatin remodeller that maintains telomere homeostasis. Loss of ATRX is described in approximately 10% of pancreatic neuroendocrine tumours (PanNETs) and associated with poorer prognostic features. Here, we present a genetically engineered mouse model (GEMM) addressing the role of Atrx loss (AtrxKO) in pancreatic β cells, evaluating a large cohort of ageing mice (for up to 24 months (mo.)). Atrx loss did not cause PanNET formation but rather resulted in worsening of ageing-related pancreatic inflammation and endocrine dysfunction in the first year of life. Histopathological evaluation highlighted an exacerbated prevalence and intensity of pancreatic inflammation, ageing features, and hepatic steatosis in AtrxKO mice. Homozygous floxed mice presented hyperglycaemia, increased weights, and glucose intolerance after 6 months, but alterations in insulinaemia were not detected. Floxed individuals presented an improper growth of their pancreatic endocrine fraction that may explain such an endocrine imbalance. A pilot study of BRACO-19 administration to AtrxKO mice resulted in telomere instability, reinforcing the involvement of Atrx in the maintenance of β cell telomere homeostasis. Thereby, a non-obese dysglycaemic GEMM of disrupted Atrx is here presented as potentially useful for metabolic studies and putative candidate for inserting additional tumourigenic genetic events.